Axonal damage is implicated in the neuropathology of depression and cognitive dysfunction. Consequently, neurofilament light protein is an emerging biomarker with potential in depression and cognitive function. Results are more consistent for cognition, requiring more research to assess neurofilament light protein in depression as well as other psychiatric disorders. Future longitudinal studies are necessary to determine whether neurofilament light protein can predict the onset and progression of depression and measure the effectiveness of potential psychiatric interventions and medications.
Advances in the pathophysiology of bipolar disorder
Bipolar disorder (BD) is a chronic and often severe psychiatric disorder affecting approximately 1–4%of the world population. There are three types of BD, including bipolar I disorder (BD-I), bipolar II disorder (BD-II), and cyclothymic disorder. All three types involve clear changes in mood, energy, and activity levels. Leer texto completo
